Edward J. Ludwig - 02 May 2024 Form 4 Insider Report for CVS HEALTH Corp (CVS)

Reporting relationship: Director
Issuer ticker: CVS
Reported as of: 02 May 2024
Net transaction value: +$53,879
SEC form: 4
Accepted by SEC: 02 May 2024, 16:31:44 UTC
Prior SEC filing: 29 Apr 2024
Next SEC filing: 13 May 2024
Source filing: View source filing
Reporting owner signature: /s/ Edward J. Ludwig

Key filing fact

Edward J. Ludwig filed Form 4 for CVS HEALTH Corp (CVS) on 02 May 2024.

Key facts

This page summarizes Edward J. Ludwig's Form 4 filing for CVS HEALTH Corp (CVS).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 02 May 2024, 16:31.

Change

Previous filing in this sequence was filed on 29 Apr 2024.
Current net transaction value: +$53,879.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CVS transaction

Common Stock

Purchase

Transaction value: $53,879
Shares: +1,000
Change %: +4.8%
Price: $53.88
Shares after: 21,630
Date: 02 May 2024
Ownership: Direct

CVS holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 11,079
Date: 02 May 2024
Ownership: By Rev Trust

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CVS holding Derivative

Share Credits

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14,653
Date: 02 May 2024
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 14,653
Exercise price: $0.000000
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Consists of deferred stock compensation payable pursuant to Reporting Person's election.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .